Published in Curr HIV/AIDS Rep on December 01, 2014
Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model. J Virol (2015) 0.76
Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada. Sex Transm Infect (2016) 0.75
HIV incidence and predictors of HIV acquisition from an outside partner in serodiscordant couples in Lusaka, Zambia, 1995-2012. J Acquir Immune Defic Syndr (2017) 0.75
Comparison of Knowledge, Attitudes, and Practices of Educated and Uneducated Adults Regarding Human Immunodeficiency Virus in Karachi, Pakistan. Cureus (2017) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med (1996) 5.63
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med (2011) 5.21
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Hormonal contraception and the risk of HIV acquisition. AIDS (2007) 5.05
Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ (2010) 4.75
Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann (2010) 4.37
Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19
Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000). HIV Clin Trials (2001) 3.68
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS (2011) 3.61
U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep (2010) 3.52
Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care (2001) 3.31
Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med (2003) 3.26
The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS (1998) 2.80
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis (2008) 2.76
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis (2013) 2.70
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS (2000) 2.61
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS (2007) 2.44
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect (2011) 2.21
Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS (2010) 2.17
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.11
From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect (2008) 2.09
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol (2006) 2.04
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis (2004) 2.03
Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS (2010) 2.03
Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr (2010) 2.01
Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev (2009) 1.95
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Long-term observation of adolescents initiating HAART therapy: three-year follow-up. AIDS Res Hum Retroviruses (2007) 1.84
PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS (2007) 1.75
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception (2007) 1.72
Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis (1994) 1.70
Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS (2010) 1.68
Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod (2007) 1.67
Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol (2012) 1.65
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception (2014) 1.65
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol (1997) 1.62
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS (2004) 1.61
Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis (2004) 1.61
Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS (2003) 1.60
A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sex Transm Dis (2010) 1.57
Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis (2002) 1.57
Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis (2000) 1.52
A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav (2009) 1.52
Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol (2000) 1.50
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS (2003) 1.45
The use of condoms with other contraceptive methods among young men and women. Fam Plann Perspect (1998) 1.44
Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS (2012) 1.41
Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses (1998) 1.38
Innate immune defences in the human endometrium. Reprod Biol Endocrinol (2003) 1.35
Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS (2004) 1.35
Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS (2013) 1.34
Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology (2006) 1.34
Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS (2013) 1.33
Women living with HIV in South Africa and their concerns about fertility. AIDS Behav (2009) 1.28
Correlates of using dual methods for sexually transmitted diseases and pregnancy prevention among high-risk African-American female teens. J Adolesc Health (2001) 1.27
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS (2012) 1.26
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Factors impacting knowledge and use of long acting and permanent contraceptive methods by postpartum HIV positive and negative women in Cape Town, South Africa: a cross-sectional study. BMC Public Health (2012) 1.24
Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG (2012) 1.24
Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses (2012) 1.23
Contraceptive use among U.S. women with HIV. J Womens Health (Larchmt) (2007) 1.20
Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One (2011) 1.19
Influence of ovarian hormones on urogenital infection. Sex Transm Infect (1998) 1.19
Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS (2004) 1.19
The effectiveness of a fertility awareness based method to avoid pregnancy in relation to a couple's sexual behaviour during the fertile time: a prospective longitudinal study. Hum Reprod (2007) 1.18
Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS (2013) 1.17
HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk? PLoS One (2009) 1.16
Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis (2009) 1.14
Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sex Transm Dis (2000) 1.14
Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. AIDS (2013) 1.13
Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids (2011) 1.13
Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994-2006. Contraception (2010) 1.11
Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. Hum Reprod (2006) 1.11
Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS (2013) 1.11
Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology (2006) 1.08
Effects of ovarian steroids on immunoglobulin-secreting cell function in healthy women. Clin Diagn Lab Immunol (2003) 1.07
Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J Immunol (2002) 1.06
Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques. AIDS (2014) 1.06
Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res Hum Retroviruses (1998) 1.05
Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. J Infect Dis (2014) 1.05
Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception (2011) 1.04
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS (1999) 1.03
Combined use of condoms with other contraceptive methods among inner-city Baltimore women. Fam Plann Perspect (1995) 1.01
Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J Immunol (2008) 1.01
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis (2001) 1.01
Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol (1997) 1.01
Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women. J Infect Dis (2003) 1.00
Improved access increases postpartum uptake of contraceptive implants among HIV-positive women in Rwanda. Eur J Contracept Reprod Health Care (2009) 0.99
Adolescent dual use of condoms and hormonal contraception: trends and correlates 1991-2001. Sex Transm Dis (2003) 0.99
Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens. Curr Womens Health Rev (2008) 0.98
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51
Avastin doesn't blind people, people blind people. Am J Ophthalmol (2012) 3.15
Abortion and long-term mental health outcomes: a systematic review of the evidence. Contraception (2008) 2.90
Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings. Lancet (2005) 2.73
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet (2012) 2.69
Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol (2007) 2.28
Cost-effectiveness of increased access to emergency contraceptive pills: probably not. Contraception (2013) 2.13
Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg (2007) 2.09
Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol (2002) 2.09
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care (2010) 1.94
Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol (2006) 1.88
Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol (2005) 1.82
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Clin Infect Dis (2012) 1.56
Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol (2007) 1.55
Entomologic investigations of a chikungunya virus epidemic in the Union of the Comoros, 2005. Am J Trop Med Hyg (2008) 1.48
Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy. Clin Immunol (2003) 1.45
Increased prevalence of elevated blood pressures in HIV-infected children, adolescents and young adults. Pediatr Infect Dis J (2015) 1.40
Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. Clin Infect Dis (2013) 1.35
Socioeconomic disadvantage as a social determinant of teen childbearing in the U.S. Public Health Rep (2013) 1.34
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J (2012) 1.28
Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter? Am J Obstet Gynecol (2007) 1.25
Prevention of mother-to-child transmission of HIV-1 through breast-feeding: past, present, and future. J Infect Dis (2004) 1.24
A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr (2012) 1.18
Evidence-based choices of physicians: a comparative analysis of physicians participating in Internet CME and non-participants. BMC Med Educ (2010) 1.18
Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS (2013) 1.17
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol (2010) 1.16
Maternal and fetal outcomes among women with depression. J Womens Health (Larchmt) (2010) 1.16
High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. PLoS Negl Trop Dis (2011) 1.15
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. J Acquir Immune Defic Syndr (2010) 1.15
Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev (2005) 1.14
IgE food sensitization in infants with eczema attending a dermatology department. J Pediatr (2007) 1.11
Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol (2006) 1.11
The thymus during HIV disease: role in pathogenesis and in immune recovery. Curr HIV Res (2004) 1.11
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. PLoS Genet (2013) 1.10
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3. Vaccine (2009) 1.09
Prospective randomized clinical trial comparing patient-controlled intravenous analgesia with patient-controlled epidural analgesia after lumbar spinal fusion. Spine (Phila Pa 1976) (2003) 1.08
Re: Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. Retina (2013) 1.06
Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004. Vaccine (2005) 1.05
Regional decline of an iconic amphibian associated with elevation, land-use change, and invasive species. Conserv Biol (2011) 1.04
Late rapid deterioration after endoscopic third ventriculostomy: additional cases and review of the literature. J Neurosurg (2006) 1.03
Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol (2007) 1.03
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study. AIDS Res Hum Retroviruses (2012) 1.03
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complement Altern Med (2012) 1.02
Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol (2012) 1.02
Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol (2013) 1.01
Effect of a low-allergen maternal diet on colic among breastfed infants: a randomized, controlled trial. Pediatrics (2005) 1.00
Neural signals of extinction in the inhibitory microcircuit of the ventral midbrain. Nat Neurosci (2012) 1.00
Pregnancy and infection. N Engl J Med (2014) 0.99
Views of biobanking research among Alaska native people: the role of community context. Prog Community Health Partnersh (2012) 0.99
HIV and metabolic, body, and bone disorders: what we know from low- and middle-income countries. J Acquir Immune Defic Syndr (2014) 0.98
Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess. J Infect (2012) 0.98
Application of enterococci antibiotic resistance patterns for contamination source identification at Huntington Beach, California. Mar Pollut Bull (2003) 0.98
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 0.97
Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. AIDS (2015) 0.97
Dopamine stimulation of postnatal murine subventricular zone neurogenesis via the D3 receptor. J Neurochem (2010) 0.95
The role of drugs and alcohol in rape. Med Sci Law (2006) 0.93
An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS (2004) 0.93
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor. MAbs (2011) 0.92
Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards. Contraception (2012) 0.92
Male circumcision and prevention of HIV and sexually transmitted infections. Curr Infect Dis Rep (2008) 0.92
Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection. Immunology (2008) 0.91
Hospitalizations with amphetamine abuse among pregnant women. Obstet Gynecol (2008) 0.90
The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90
Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 0.90
Effect of cytomegalovirus infection on breastfeeding transmission of HIV and on the health of infants born to HIV-infected mothers. AIDS (2015) 0.89
Selenium toxicity: a case of selenosis caused by a nutritional supplement. Ann Intern Med (2008) 0.89
Gastrostomy placement in paediatric patients with neuromuscular disorders: indications and outcome. Dev Med Child Neurol (2007) 0.89
Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines. Retrovirology (2012) 0.89
Transition to adulthood and antiretroviral adherence among HIV-positive young Black men who have sex with men. Am J Public Health (2014) 0.88
Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know? J Acquir Immune Defic Syndr (2014) 0.87
Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis (2011) 0.87
Psychosocial support for youth living with HIV. Pediatrics (2014) 0.87
Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation (2014) 0.87
Resources, roadblocks and turning points: a qualitative study of American Indian/Alaska Native adults with type 2 diabetes. J Community Health (2013) 0.87
A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Syst Rev (2014) 0.86
Evaluation of a volunteer community-based health worker program for providing contraceptive services in Madagascar. Contraception (2013) 0.85
Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding. AIDS (2015) 0.85
Route of delivery and neonatal birth trauma. Am J Obstet Gynecol (2010) 0.85
Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART). J Womens Health (Larchmt) (2007) 0.85
Changing stigma through a consumer-based stigma reduction program. Community Ment Health J (2013) 0.85
Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations. J Clin Pharmacol (2014) 0.85
Hydrodynamic pressure sensing with an artificial lateral line in steady and unsteady flows. Bioinspir Biomim (2012) 0.85
Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies. Contraception (2012) 0.85
Maternal weight loss during exclusive breastfeeding is associated with reduced weight and length gain in daughters of HIV-infected Malawian women. J Nutr (2013) 0.84
Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection? J Infect Dis (2010) 0.84
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study. Antivir Ther (2014) 0.84
Influenza and pregnant women: hospitalization burden, United States, 1998-2002. J Womens Health (Larchmt) (2006) 0.84
A qualitative analysis of father-son relationships among HIV-positive young black men who have sex with men. J Urban Health (2014) 0.84
Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. Gut (2013) 0.84
Poisoning hospitalisations among reproductive-aged women in the USA, 1998-2006. Inj Prev (2011) 0.84
Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients. AIDS (2015) 0.84
Public figure announcements about cancer and opportunities for cancer communication: a review and research agenda. Health Commun (2013) 0.83
Mycobacterium abscessus as a cause of pacemaker infection. Med Sci Monit (2004) 0.83
Growth, morbidity, and mortality in a cohort of institutionalized HIV-1-infected African children. J Acquir Immune Defic Syndr (2003) 0.83
Recent Biomarker-Confirmed Unprotected Vaginal Sex, But Not Self-reported Unprotected Sex, Is Associated With Recurrent Bacterial Vaginosis. Sex Transm Dis (2016) 0.82
Cryptococcus neoformans as a cause of bronchiolitis obliterans organizing pneumonia. J Infect Chemother (2010) 0.82
Discord among performance measures for central line-associated bloodstream infection. Infect Control Hosp Epidemiol (2012) 0.81
Desmitis of the straight sesamoidean ligament in horses: 9 cases (1995-1997). J Am Vet Med Assoc (2003) 0.81